2024
Impact of COVID-19 on women living with HIV who are survivors of intimate partner violence
Zhang X, Price C, Pope A, Sullivan T, Meyer J. Impact of COVID-19 on women living with HIV who are survivors of intimate partner violence. BMC Public Health 2024, 24: 1352. PMID: 38769576, PMCID: PMC11103830, DOI: 10.1186/s12889-024-18862-7.Peer-Reviewed Original ResearchConceptsIntimate partner violenceIntimate partner violence exposureLifetime intimate partner violencePartner violenceRates of intimate partner violenceSurvivors of intimate partner violenceIntimate partner violence survivorsSubstance usePhysical healthMental healthImpact of COVID-19Experiences of WLWHImpact domainsHIV care engagementSubstance use problemsConcurrent mental healthIPV survivorsSample of WLWHCOVID-19-related impactsHealth emergency periodMultivariate linear regression modelPrimary explanatory variablePearson chi-square testCare engagementGroup of women
2022
A PrEP Demonstration Project Using eHealth and Community Outreach to Justice-Involved Cisgender Women and Their Risk Networks
Meyer JP, Price CR, Ye Y, Qin Y, Tracey D, Demidont AC, Melbourne K, Altice FL. A PrEP Demonstration Project Using eHealth and Community Outreach to Justice-Involved Cisgender Women and Their Risk Networks. AIDS And Behavior 2022, 26: 3807-3817. PMID: 35672552, DOI: 10.1007/s10461-022-03709-2.Peer-Reviewed Original ResearchConceptsTDF/FTCPrEP care continuumPre-exposure prophylaxisPrimary care providersPrEP demonstration projectRisk network membersNon-Hispanic whitesCisgender womenOutreach modelRespondent-driven samplingPrEP awarenessCommunity outreach modelEnrolled participantsMean ageClinical criteriaIndex participantsCare continuumHIV preventionSocial comorbiditiesCare providersKey populationsPrEPSubstance useMedical insuranceWomen
2021
Chapter 11 HIV pre-exposure prophylaxis for people who inject drugs
Shrestha R, McCoy-Redd B, Meyer J. Chapter 11 HIV pre-exposure prophylaxis for people who inject drugs. 2021, 223-236. DOI: 10.1016/b978-0-323-68328-9.00011-4.Peer-Reviewed Original ResearchHIV preventionEffective HIV prevention toolHigh-risk sexual networksHIV pre-exposure prophylaxisLimited clinical trial dataSubstance usePre-exposure prophylaxisHIV prevention toolClinical trial dataHarm reduction programsKey target populationSubstance use disordersPart of patientsTarget populationPrEP outcomesPreexposure prophylaxisMedication adherenceHIV riskUse disordersTrial dataPWIDSexual networksPrEPPrevention toolProphylaxis